Trade

Hemo Organic share price

High risk
  • 63%Low risk
  • 63%Moderate risk
  • 63%Balanced risk
  • 63%High risk
  • 63%Extreme risk
  • 15.10(4.93%)
    May 15, 2026 15:06:06 PM IST
    • NSE
    • BSE
  • Vol : 5.08 K (NSE + BSE)
    Last 20 day avg : 10.06 K

Hemo Organic is trading 4.93% upper at Rs 15.10 as compared to its last closing price. Hemo Organic has been trading in the price range of 15.10 & 15.10. Hemo Organic has given -16.24% in this year & 7.95% in the last 5 days. Hemo Organic has TTM P/E ratio 64.04 as compared to the sector P/E of 24.31.The company posted a net profit of -0.16 Crores in its last quarter.Listed peers of Hemo Organic include Divi's Laboratories (-2.41%), Torrent Pharmaceuticals (-0.52%), Cipla (-0.49%).The Mutual Fund holding in Hemo Organic was at -% in . The MF holding has - from the last quarter. The FII holding in Hemo Organic was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 16, 2026, 12:16 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.66
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
15.10
Highest
15.10
52 week range
Lowest
8.08
Highest
22.51
Hemo Organic Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Bullish
6,755.00-2.411,78,679.9980.4811.80.450.01
Torrent Pharmaceuticals
Bullish
4,386.00-0.521,48,148.9275.0619.060.8217.62
Cipla
Moderately Bullish
1,431.55-0.491,16,013.1020.463.450.970.81
Sun Pharmaceutical Industries
Bullish
1,879.900.904,51,076.6737.996.050.910.50
Lupin
Neutral
2,273.900.711,04,095.4132.016.220.5111.80
Hemo Organic Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-13Quarterly Results
2025-11-14Quarterly Results & Preferential issue
2025-08-13Quarterly Results
2025-05-20Audited Results
2025-02-06Quarterly Results
About the company Hemo Organic
  • IndustryBiotechnology & Drugs
  • ISININE422G01015
  • BSE Code524590
  • NSE Code
Hemo Organic Limited is an India-based company engaged in the manufacturing of ayurvedik or unani pharmaceutical preparations. The Company is presently engaged in the business of manufacturing, trading, and dealing with chemicals, dyes, pigments, auxiliaries, intermediates, heavy and fine chemicals, organic and inorganic chemicals, among others. It is also engaged in formulation, processing, and development of pharmaceutical products, nutraceuticals, and healthcare supplements.
  • Management Info
  • Murlidhar JoshiChief Financial Officer, Non-Executive Director
  • Yukta PatelCompany Secretary and Compliance Officer
  • Vishwambar SinghManaging Director, Executive Director
Hemo Organic Share Price FAQs

Hemo Organic is trading at 15.10 as on Fri May 15 2026 09:36:06. This is 4.93% upper as compared to its previous closing price of 14.39.

The market capitalization of Hemo Organic is 5.24 Cr as on Fri May 15 2026 09:36:06.

The 52 wk high for Hemo Organic is 22.51 whereas the 52 wk low is 8.08

Hemo Organic can be analyzed on the following key metrics -

  • TTM P/E: 64.04
  • Sector P/E: 24.31
  • Dividend Yield: 0.00%
  • D/E ratio: -

Hemo Organic reported a net profit of 0.16 Cr in 2025.